Clinical Trials

Argos is committed to bringing promising therapies from the lab to the patient, quickly and efficiently. To that end, we both conduct corporate clinical trials and sponsor investigator research, collaborating with some of the world’s leading experts in immunotherapy.

Argos is leveraging the encouraging results from investigator-sponsored clinical trials of its dendritic cell technology to accelerate the clinical development and commercial introduction of the company’s cancer vaccines, including a Phase I/II corporate clinical trial in metastatic renal cell carcinoma.